Borderline resectable pancreatic cancer: need for standardization and methods for optimal clinical trial design.
Borderline resectable pancreatic cancer: need for standardization and methods for optimal clinical trial design. Ann Surg Oncol. 2013 Aug; 20(8):2787-95.